Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
Galectin-3 is a protein naturally found in the body that helps cells stick together, communicate, and respond to injury or infection. It also plays a role in inflammation, tissue repair, and the formation of scar tissue. In cancer, galectin-3 may help tumor cells survive, spread, and avoid the immune system. Modified Citrus Pectin (MCP) is a dietary supplement made by breaking down pectin from citrus fruits into smaller pieces that the body can absorb. MCP is thought to bind to galectin-3 and block some of its actions, a process called galectin-3 inhibition.
Researchers have found that galectin-3 may contribute to cancer growth and spread by helping tumor cells stick to each other and to other tissues, promoting new blood vessel formation, and affecting immune responses. Because of this, scientists are exploring whether blocking galectin-3 with substances like MCP might slow cancer progression or improve treatment outcomes. While laboratory and animal studies show some promising effects, strong evidence from human clinical trials is still lacking. MCP is not an approved cancer treatment but is sometimes used as a complementary approach to support overall health, symptom relief, or recovery during cancer care.
Patients may hear about MCP as a natural supplement that could help reduce cancer spread or support the immune system. It may be mentioned in integrative oncology discussions, patient support programs, or alternative health sources. Some people use MCP hoping to improve energy, appetite, or quality of life, especially when standard treatments are difficult or cause side effects. However, experiences vary widely—some report benefits, while others notice no change or experience mild digestive side effects. MCP products differ in formulation and dose, so it is important to use them carefully and under medical supervision.
The term Modified Citrus Pectin or Galectin-3 Inhibition may appear in medical records, treatment plans, clinical trial descriptions, or patient education materials. It might also come up during discussions about supportive care, nutrition, or complementary therapies. Because MCP is a dietary supplement, it is often found in alternative health literature or integrative oncology programs rather than standard cancer treatment guidelines.
Seeing the term does not mean MCP is a proven cancer cure or that it replaces standard treatments like surgery, chemotherapy, or radiation. It also does not guarantee symptom relief or improved survival. Laboratory findings do not always translate into real benefits for patients. MCP use should not delay or interfere with effective cancer therapies. It is important to avoid unrealistic expectations and to understand that MCP is considered experimental and supportive rather than a primary cancer treatment.
Anyone considering MCP during cancer treatment should talk with their healthcare team first. MCP may interact with medications or affect treatment tolerance, especially if you have surgery planned, are receiving chemotherapy, radiation, immunotherapy, or taking blood thinners or diabetes drugs. It may also affect people with kidney or liver problems, bowel obstruction, or immune suppression differently. Your care team can help weigh potential benefits and risks and monitor for side effects or interactions.
If you come across Modified Citrus Pectin or galectin-3 inhibition in your care, ask your doctor or nurse what it means for your specific situation. Discuss any supplements you are taking or considering, and how they might fit with your treatment plan. Reliable information and open communication can help you make informed choices and avoid confusion or harm. Remember that MCP is one of many complementary approaches people explore, but it should never replace recommended cancer treatments or medical advice.
Public source information used for this glossary entry includes: